Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
92 2nd Street
Hackensack, NJ 07601Phone+1 551-996-8297Fax+1 551-996-0575
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2013 - Present
NJ State Medical License 2022 - 2025
NY State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- Role of Endoscopic Techniques in the Diagnosis of Complications of Allogeneic Hematopoietic Stem Cell Transplantation: A Review of the Literature.Ayrton Bangolo, Shraboni Dey, Vignesh Krishnan Nagesh, Kabir Gumer, Lida Avetisyan
Journal of Clinical Medicine. 2024-07-25 - Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades.Ayrton Bangolo, Pierre Fwelo, Shraboni Dey, Tanni Sethi, Sowmya Sagireddy
World Journal of Clinical Oncology. 2024-06-24 - Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.Giovanna Melica, Elaina Preston, Meighan Palazzo, Kenneth Seier, Florent Malard
Bone Marrow Transplantation. 2024-05-01
Abstracts/Posters
- Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell TransplantationChristina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant AbstractChristina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
